Literature DB >> 8599350

Evidence for a discrete behavioral phenotype in the oculocerebrorenal syndrome of Lowe.

L Kenworthy1, L Charnas.   

Abstract

The oculocerebrorenal syndrome of Lowe (OCRL) is an X-linked disorder characterized by congenital cataracts, cognitive impairment, and renal tubular dysfunction. Although there is a wide range of intellectual function in affected individuals, it is often compromised by a high prevalence of maladaptive behaviors, including tantrums, stubborness, and stereotypy. Whether these behaviors simply reflect the multiple disabilities found in some developmentally impaired individuals with or without OCRL, or a specific genetically-determined behavioral phenotype of OCRL, is unknown. Controls were matched for sex, age, visual impairment, and adaptive functioning and compared with OCRL patients on three standardized measures of adaptive/maladaptive behaviors. Forty-three matched pairs of OCRL and control subjects were identified. Both groups were similar in communication, daily living, socialization, and motor skills, in socioeconomic status, and in measures of parental stress. Individuals with OCRL displayed significantly more severe maladaptive behaviors than control boys, as measured by the Vineland Adaptive Behavior Scales (VABS), with 41% of the difference between the two groups attributable to the diagnosis of OCRL. Twelve maladaptive behaviors measured on the VABS appeared more frequently in OCRL than in controls. Five of these 12 behaviors, i.e., temper tantrums, irritability, complex repetitive behaviors (stereotypy)/mannerisms, obsessions/unusual preoccupations, and negativism, were identified by discriminant function analysis to significantly distinguish between controls and OCRL individuals. The diagnosis of OCRL is associated with a behavioral phenotype consisting of temper tantrums, stereotypy, stubborness, and obsessions/unusual preoccupations. This phenotype cannot be attributed solely to the visual, motor, and intellectual disabilities characteristic of OCRL, and may represent a specific effect of the OCRL gene on the central nervous system.

Entities:  

Mesh:

Year:  1995        PMID: 8599350     DOI: 10.1002/ajmg.1320590304

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  12 in total

1.  Mouse model for Lowe syndrome/Dent Disease 2 renal tubulopathy.

Authors:  Susan P Bothwell; Emily Chan; Isa M Bernardini; Yien-Ming Kuo; William A Gahl; Robert L Nussbaum
Journal:  J Am Soc Nephrol       Date:  2010-12-23       Impact factor: 10.121

2.  Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice.

Authors:  P A Jänne; S F Suchy; D Bernard; M MacDonald; J Crawley; A Grinberg; A Wynshaw-Boris; H Westphal; R L Nussbaum
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

3.  Increased levels of plasma lysosomal enzymes in patients with Lowe syndrome.

Authors:  A J Ungewickell; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

4.  A structural basis for Lowe syndrome caused by mutations in the Rab-binding domain of OCRL1.

Authors:  Xiaomin Hou; Nina Hagemann; Stefan Schoebel; Wulf Blankenfeldt; Roger S Goody; Kai S Erdmann; Aymelt Itzen
Journal:  EMBO J       Date:  2011-03-04       Impact factor: 11.598

5.  Two closely related endocytic proteins that share a common OCRL-binding motif with APPL1.

Authors:  Laura E Swan; Livia Tomasini; Michelle Pirruccello; Joël Lunardi; Pietro De Camilli
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-02       Impact factor: 11.205

6.  The prevalence and phenomenology of repetitive behavior in genetic syndromes.

Authors:  Joanna Moss; Chris Oliver; Kate Arron; Cheryl Burbidge; Katy Berg
Journal:  J Autism Dev Disord       Date:  2008-11-27

7.  Species-specific difference in expression and splice-site choice in Inpp5b, an inositol polyphosphate 5-phosphatase paralogous to the enzyme deficient in Lowe Syndrome.

Authors:  Susan P Bothwell; Leslie W Farber; Adam Hoagland; Robert L Nussbaum
Journal:  Mamm Genome       Date:  2010-09-26       Impact factor: 2.957

8.  Recognition of the F&H motif by the Lowe syndrome protein OCRL.

Authors:  Michelle Pirruccello; Laura E Swan; Ewa Folta-Stogniew; Pietro De Camilli
Journal:  Nat Struct Mol Biol       Date:  2011-06-12       Impact factor: 15.369

Review 9.  The oculocerebrorenal syndrome of Lowe: an update.

Authors:  Arend Bökenkamp; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2016-03-24       Impact factor: 3.714

10.  A role of OCRL in clathrin-coated pit dynamics and uncoating revealed by studies of Lowe syndrome cells.

Authors:  Ramiro Nández; Daniel M Balkin; Mirko Messa; Liang Liang; Summer Paradise; Heather Czapla; Marco Y Hein; James S Duncan; Matthias Mann; Pietro De Camilli
Journal:  Elife       Date:  2014-08-08       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.